Robin Park1, Jong Dae Ji2. 1. Division of Rheumatology, College of Medicine, Korea University, 126-1, Anam-Dong 5-Ga, Sungbuk-Ku, Seoul, 136-705, South Korea. 2. Division of Rheumatology, College of Medicine, Korea University, 126-1, Anam-Dong 5-Ga, Sungbuk-Ku, Seoul, 136-705, South Korea. jjdjmesy@korea.ac.kr.
Abstract
INTRODUCTION: Inflammatory bone resorption causes progressive joint destruction which ultimately leads to functional disability in rheumatoid arthritis (RA). The primary cell responsible for bone resorption is the osteoclast, which means it is a potential therapeutic target against bone destruction. In fact, experimental and clinical findings suggest that blockade of osteoclast differentiation and function is highly effective in inhibiting bone destruction in RA. DISCUSSION AND CONCLUSION: In this report, we show several lines of experimental evidence which suggest that a variety of Ca(2+) channels are essential in osteoclast differentiation and function, and present a hypothesis that modulation of Ca(2+) channels is a highly effective therapeutic strategy in preventing osteoclast-induced structural damage in RA.
INTRODUCTION: Inflammatory bone resorption causes progressive joint destruction which ultimately leads to functional disability in rheumatoid arthritis (RA). The primary cell responsible for bone resorption is the osteoclast, which means it is a potential therapeutic target against bone destruction. In fact, experimental and clinical findings suggest that blockade of osteoclast differentiation and function is highly effective in inhibiting bone destruction in RA. DISCUSSION AND CONCLUSION: In this report, we show several lines of experimental evidence which suggest that a variety of Ca(2+) channels are essential in osteoclast differentiation and function, and present a hypothesis that modulation of Ca(2+) channels is a highly effective therapeutic strategy in preventing osteoclast-induced structural damage in RA.
Authors: Iannis E Adamopoulos; Marlowe Tessmer; Cheng-Chi Chao; Sarvesh Adda; Dan Gorman; Mary Petro; Chuan-Chu Chou; Robert H Pierce; Wei Yao; Nancy E Lane; Drake Laface; Edward P Bowman Journal: J Immunol Date: 2011-06-13 Impact factor: 5.422
Authors: Robin K Dore; Stanley B Cohen; Nancy E Lane; William Palmer; William Shergy; Lifen Zhou; Huei Wang; Wayne Tsuji; Richard Newmark Journal: Ann Rheum Dis Date: 2009-09-03 Impact factor: 19.103
Authors: Mimi N Phan; Holly A Leddy; Bartholomew J Votta; Sanjay Kumar; Dana S Levy; David B Lipshutz; Suk Hee Lee; Wolfgang Liedtke; Farshid Guilak Journal: Arthritis Rheum Date: 2009-10
Authors: Mikhail Y Kochukov; Terry A McNearney; Huaizhi Yin; Liping Zhang; Fei Ma; Larissa Ponomareva; Sarah Abshire; Karin N Westlund Journal: Mol Pain Date: 2009-08-20 Impact factor: 3.395